The Aesthetic and Beauty Industry Council (ABIC) has officially launched the Menopause Aesthetics Division, a national-first initiative to lead the ethical integration of menopause-focused care into medical aesthetic practice. Coined and formalised by ABIC, the term Menopause Aesthetics represents a newly recognised category that addresses the intersection between hormonal ageing and aesthetic intervention.
The Division has been established to address the increasing number of women seeking aesthetic support during perimenopause and menopause, a client group whose needs are often medically complex, emotionally nuanced and underserved by formal protocols. In response, ABIC is building a framework of professional standards that reflect the highest levels of clinical integrity and evidence-based care.
The initiative will be governed by a multidisciplinary Menopause Aesthetics Committee, including senior professionals across aesthetic medicine, general practice, cosmetic nursing, dermal science, education and allied health. Their focus will be on establishing:
- A national Code of Conduct for menopause-related advertising and clinical communication
- Best practice consultation and treatment guidelines
- Endorsed educational pathways aligned with scope of practice
- A certification model for qualified menopause aesthetics practitioners and clinics
- Referral protocols that strengthen continuity of care between medical and aesthetic providers
‘Medical aesthetic professionals are uniquely positioned to support women navigating hormonal change, but that privilege requires structure, ethics and evidence,’ said Stefanie Milla, CEO and Founding Director of ABIC. ‘This Division allows us to progress aesthetic care for menopausal women in a way that upholds medical responsibility and client trust, while also protecting the profession from misinformation, exploitation, or reactive regulation.’
